SonoThera™

Sonothera Therapeutics

This company develops a non-viral gene therapy platform using ultrasound and microbubbles to deliver genetic medicines for patients with serious diseases.

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.

Immitra Bio

This company develops an in-vivo gene editing platform to provide off-the-shelf curative treatments for patients with rare genetic diseases.

Exact Therapeutics

The company develops an ultrasound-mediated platform for delivering targeted therapies to patients with cancer, neurological conditions and infectious diseases.

Aera Therapeutics

This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.

Code Bio

This company develops non-viral genetic medicine delivery platforms and therapies for patients with rare and prevalent genetic diseases.

Surf Therapeutics

This company develops non-invasive ultrasound devices to treat patients with chronic inflammatory disorders by stimulating the cholinergic anti-inflammatory pathway.

Borea Therapeutics

The company develops bio-conjugated viral vectors for gene therapy to treat patients with genetic or chronic diseases.